A cross-sectional study of seroepidemiology of viral hepatitis among Uighurs in Shufu of Xinjiang
10.3760/cma.j.issn.0253-9624.2017.06.006
- VernacularTitle: 新疆疏附县维吾尔族人群病毒性肝炎血清流行病学现况调查
- Author:
Zhoubin ZHANG
1
;
Zhenxiang XUE
2
;
Qiongying YANG
;
Tongmin WANG
;
Yaohui LI
;
Chunying MA
;
Xuelian SONG
;
Gang WANG
;
Dongmei LUO
;
Mahat SULAYMAN
;
Abdurahman RAYHANGUL
;
Caihong ZHAO
;
Yuzhong WANG
;
Ming WANG
Author Information
1. Director Room, Guangzhou Center for Disease Control and Prevention, Guangzhou 510440, China
2. Immunization Program Planning, Shufu Center for Disease Control and Prevention, Kashi 844100, China
- Publication Type:Journal Article
- Keywords:
Hepatitis;
Antibodies;
Antigens;
Uygur
- From:
Chinese Journal of Preventive Medicine
2017;51(6):484-489
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the status of seroepidemiology on hepatitis A, B and C among students and residents aged equal or greater than 18 years in south Xinjiang, and to provide scientific evidence for prevention and control of viral hepatitis.
Methods:Uyghur students in four towns and villages were selected by cluster random sampling from Feb to May, 2015, and Uyghur residents aged 18 to 69 years were selected by stratified cluster sampling from May to September, 2016. 4 507 middle and primary Uygur students and 4 833 Uyghur resides equal or greater than 18 years attended this survey. Self-designed questionnaire was used to collect the demographic information. And Elisa test was adopted to detect HAV-IgG, HBsAg, HBsAb and HCV-IgG. Chi-square test was used to calculate the difference on antibody positive rate of three types of hepatitis among the participants.
Results:The overall HAV-IgG positive rate was 99.45% (9 289/9 340). The positive rates were 99.70% (4 006/4 018) in male and 99.27% (5 283/5 322) in female (χ2=7.95, P=0.005). The HAV-IgG positive rate among people aged 10 to 14 years was the highest (99.91%, 2 233/2 235), and the difference between the age specific HAV-IgG positive rates was statistical significant (χ2=38.21, P<0.001). The overall HBsAg positive rate was 4.11% (384 cases), with 4.55% (183 cases) for male and 3.78% (201 cases) for female. The HBsAg positive rate among participants 19 to 24 years old was the highest (9.46%, 21/222) and the differences between the age specific HBsAg was statistically significant (χ2=116.22, P<0.001). The HBsAb positive rate was 35.03% (3 272 cases), with 35.59% (1 430 cases) for male and 34.61% (1 842 cases) for female, and the HBsAb positive rate among participants aged 15 to 18 years was the highest, which was 69.12% (696/1 007). The differences between the age specific HBsAb rates appeared statistically significant (χ2=671.80, P<0.001). The overall HCV-IgG positive rate was 0.65%(61 cases). The HCV-IgG positive rate in female was 0.86% (46 cases) and 0.37% (15 cases) in male (χ2=8.51, P=0.004).The HCV-IgG positive rate among participants aged over 70 years was the highest (3.78%,9/238) , and the difference between the age specific HCV-IgG positive rates had statistic significance (χ2=70.30, P<0.001). The HAV-IgG positive rate in hepatitis A vaccinees (100%, 876/876) was higher than that among the non-vaccinees (99.40%, 8 413/8 464) (χ2=4.26, P=0.039). The HBsAb positive rate in hepatitis B vaccinees was 39.32% (1 816/4 619) which was higher than that among the non-vaccinees (30.84%, 1 456/4 721) (χ2=73.68, P<0.001).
Conclusion:The positive rate of overall HAV-IgG was high, male and participants aged between 10 to 14 had higher probability to be infected. But the infection rates of hepatitis B and C were low, with the low vaccination rate and the poor protective effectiveness of hepatitis B.
